Astellas Pharma's total assets for Q2 2026 were ¥3.45T, an increase of 3.43% from the previous quarter. JP:4503 total liabilities were ¥1.84T for the fiscal quarter, a -0.87% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.